This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on host microbiome analysis driven personalized nutrition solutions and precision probiotics development. Newer drug delivery carriers such as RBC derived vesicles, non viral gene delivery carriers and a few innovations around gene circuits for advanced therapeutics have also been covered.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
GROWTH PIPELINE DIALOG™
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.